Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31091157 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL31091156 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL31509123 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL31091155 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| Cembrene_A SCHEMBL11402150 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| SCHEMBL23360384 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| Cembrene_A SCHEMBL31309845 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| Cembrene_A SCHEMBL2041140 | 1.00 | LMNA (0.86) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| (-)-Limonene SCHEMBL8829 | 0.93 | LMNA (1.00) | LMNAALDH1A1ALOX15CYP1B1TSHR | |
| (-)-Limonene SCHEMBL797520 | 0.93 | LMNA (1.00) | LMNAALDH1A1ALOX15CYP1B1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120041408-A | Beta-elemene synthase and application thereof in preparation of beta-elemene | 中医药广东省实验室 | 2025-05-27 | — | — | CN | disclosed |
| US-20250075243-A1 | BIOSYNTHESIS OF OXYGENATED HYDROCARBONS | GINKGO BIOWORKS, INC. (US) | 2025-03-06 | — | — | US | disclosed |
| US-20250027070-A1 | ENGINEERED SESQUITERPENE SYNTHASES | GINKGO BIOWORKS, INC. (US) | 2025-01-23 | — | — | US | disclosed |
| EP-4460569-A1 | SKIN COMMENSAL BACTERIA ENGINEERED TO PRODUCE TERPENES | Ginkgo Bioworks, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| EP-4437097-A1 | ENGINEERED SESQUITERPENE SYNTHASES | Ginkgo Bioworks, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| US-12077799-B2 | Chimeric terpene synthases | GINKGO BIOWORKS, INC. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20240218403-A1 | BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF | GINKGO BIOWORKS, INC. (US) | 2024-07-04 | — | — | US | disclosed |
| WO-2024059517-A1 | BIOSYNTHESIS OF OXYGENATED HYDROCARBONS | GINKGO BIOWORKS, INC. (US) | 2024-03-21 | — | — | WO | disclosed |
| EP-4314271-A1 | BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF | Ginkgo Bioworks, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117460825-A | Biosynthesis of isoprenoids and their precursors | 银杏生物制品公司 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023133490-A1 | SKIN COMMENSAL BACTERIA ENGINEERED TO PRODUCE TERPENES | GINKGO BIOWORKS, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023097167-A1 | ENGINEERED SESQUITERPENE SYNTHASES | GINKGO BIOWORKS, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| WO-2022212917-A1 | BIOSYNTHESIS OF ISOPRENOIDS AND PRECURSORS THEREOF | GINKGO BIOWORKS, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| US-20210147880-A1 | CHIMERIC TERPENE SYNTHASES | GINKGO BIOWORKS, INC. (US) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250075243-A1 | BIOSYNTHESIS OF OXYGENATED HYDROCARBONS | CBR3, CBR1, DOHH | LMNA 3660/4885ALDH1A1 3432/4885ALOX15 96/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.